Microlife And The American Heart Association Form Sponsorship Agreement
TAMPA, Fla., May 11 /PRNewswire/ -- Microlife USA and the American Heart Association have announced a sponsorship agreement on a free, personalized online program that will educate consumers on the importance of heart health and the control of high blood pressure.
Under the agreement, Microlife will be a national sponsor of the American Heart Association's High Blood Pressure Patient and Professional Heart Profilers(TM), an online educational tool for patients, loved ones and caregivers and a clinical reference tool for professionals. Microlife will notate American Heart Association sponsorship on its blood pressure monitoring marketing materials. Microlife joins the American Heart Association and NexCura, Inc., the developer of the Heart Profilers tools, with a goal to generate awareness among healthcare professionals and the general public on high blood pressure and its associated risks. The program goals include facilitating dialogue between the patient and the physician and increasing participation in the Heart Profilers(TM) program (americanheart.org/heartprofilers).
"Microlife is honored by the opportunity to work with the American Heart Association," said James R. Mault, M.D., a heart surgeon and the chief medical officer of Microlife USA. "The Heart Profilers program allows people to be proactive with their heart health and take charge of it in a meaningful way."
"This sponsorship allows us to expand our reach directly to the point of retail sale and provide the most current, most actionable information available on heart-health," said Clyde Yancy, M.D., professor of medicine/cardiology at the University of Texas Southwestern Medical Center in Dallas, and an American Heart Association volunteer.
Microlife will co-market the American Heart Association's Heart Profilers programs and use its relationships with key pharmacy retailers to inform customers about this reliable source of health information. The company also will help educate customers about the importance of monitoring their blood pressure at home with a validated blood pressure monitor to ensure accuracy. Microlife's blood pressure monitors received an "A" validation grade for accuracy of systolic pressure and an "A" grade for diastolic pressure measurement against the most stringent criteria by independent researchers. The validation is based on British Hypertension Society protocol, the world's authority on home blood pressure monitoring.
About the High Blood Pressure Heart Profiler for the Patient
The online tool, specific to many heart conditions and high blood pressure, provides patients, loved ones and caregivers with standard treatment options and descriptions of possible side effects. The Heart Profilers tools also generate confidential, personalized reports that enable patients to have a more meaningful dialogue with their healthcare provider. Logon to the Heart Profilers at americanheart.org/heartprofilers.
About the High Blood Pressure Heart Profiler for the Medical Professional
This version of the online tool, dedicated to high blood pressure, will provide physicians and other healthcare professionals access to abstracts of published studies based on their patient's overall condition. The program provides a listing the types of studies, citations of relevant studies summarizing the inclusion/exclusion criteria and research findings. In addition, Heart Profilers give the professional the ability to see how a healthcare professional's patients compare to study populations in order to evaluate risk of potential outcomes associated with different treatment options. Logon to the Heart Profilers at americanheart.org/heart profilers.
About Microlife
Microlife Corporation is a global company and the world leader in the development and manufacturing of medical diagnostic equipment for home and institutional use. Microlife USA, with its headquarters in Tampa FL, offers consumers hospital grade accuracy for a variety of medical devices including blood pressure monitors, digital thermometers and digital peak flow meters. Microlife is a vertically integrated manufacturing company with a worldwide sales and distribution network. Microlife's blood pressure monitors received an "A" validation grade for accuracy of systolic pressure and "A" grade for diastolic pressure measurement against the most stringent criteria by independent researchers. The validation is based on British Hypertension Society protocol, the world's authority on home blood pressure monitoring. Microlife exports over 35 million medical devices each year from its factory in Shenzhen, China to all parts of the world. Microlife products utilize leading edge technology for monitoring key health indicators. The Microlife family consists of more than 2,400 dedicated employees worldwide and is committed to continued research and development in medical devices that enable people to responsibly manage their own health. Visit Microlife USA's website at microlifeusa.com.
About the American Heart Association
Since 1924 the American Heart Association has helped protect people of all ages and ethnicities from the ravages of heart disease and stroke. These diseases, the nation's No. 1 and No. 3 killers, claim nearly 930,000 American lives a year. The association invested more that $439 million on fiscal year 2003-04 for research, professional and public education, advocacy and community service programs so people across America can live stronger, longer lives. To learn more, visit americanheart.org.
About NexCura
NexCura, Inc., a Seattle-based company, is a clinical data and communications service business that provides proprietary, web-based, decision-support technologies for patients with chronic diseases. The company distributes its technology through a network of pre-eminent resource centers, including the American Cancer Society, the American Heart Association, the American Lung Association, patient advocacy groups, hospitals and Web portals. The patented technology enables NexCura to provide mission-critical marketing and clinical research data and services for highly targeted patient populations to the pharmaceutical, biotechnology and medical device industries. For more information about NexCura, visit the NexCura Web site at nexcura.com.
Microlife USA; The American Heart AssociationCONTACT: Teresa Barnes of Microlife USA, +1-303-521-4080,tbarnes@microlifeusa.com; or Christy Jones of American Heart Association,+1-214-706-1636, christy.jones@heart.org
Web site: http://www.nexcura.com/
Web site: http://www.americanheart.org/heartprofilers
Web site: http://www.americanheart.org/http://www.microlifeusa.com/